SU2C, MLB united in fight against cancer

October 24th, 2020

Major League pitchers Chad Bettis, Jameson Taillon and Carlos Carrasco are known for their accomplishments on the mound, but it’s their battle off the field that unites them in a unique way. Having all overcome cancer diagnoses in recent years, they understand firsthand the importance of the work Stand Up To Cancer (SU2C) is doing.

SU2C took a groundbreaking approach to accelerate innovative cancer research by encouraging collaboration in the medical community, bringing together the best and brightest researchers with the singular goal of discovering innovative cancer-fighting techniques and treatments. Then the All-Star team of doctors, scientists and researchers focused on bringing hope to cancer patients.

SU2C has formed important collaborations in sports and entertainment to generate widespread awareness and education on cancer prevention, and, in the process, helping more people with cancer diagnoses become long-term survivors. They’ve also engaged organizations like Major League Baseball -- the founding donor of SU2C -- and companies like Mastercard that share their mission to ensuring that a cancer diagnosis is only part of a patient’s story, and that a full and healthy life awaits them on the other side.

Mastercard has proudly supported Stand Up To Cancer for the past decade. Since 2010, the company, with the help of its cardholders, has donated more than $50 million to Stand Up To Cancer. They continue to find ways to engage people in the effort. In fact, now through the end of the year, when fans use their Mastercard to donate to Stand Up To Cancer, Mastercard will match what they give, dollar for dollar, up to $1,000,000. Fans can visit to make their contributions, because when we all come together for a good cause, together we can Start Something Priceless.

SU2C has received more than $625 million in donations since its founding, and those contributions have made a significant impact in the cancer research and treatment community. More than 1,950 scientists, representing more than 210 institutions, are involved in SU2C-funded research projects, and more than 180 clinical trials have been funded by the organization. In May 2020, SU2C announced its eighth FDA approval for a new cancer therapy that was supported by SU2C research.

Visit Stand Up To Cancer’s website to learn more and join the effort. Stand Up To Cancer is a division of the Entertainment Industry Foundation, a 501(c)(3) charitable organization.